A B S T R A C T In vivo androgen kinetics were determined in six young (21-49 yr) and elderly men (62-77 yr) with prostate hyperplasia (BPH). Steadystate infusions of [14C]testosterone and [3H]androstanediol (3adiol) were given, which allowed determination of the conversions testosterone -* dihydrotesterone (DHT) ti 3adiol. These infusions also yield metabolic clearance data which, together with measurement of nonisotopic steroid levels, yield estimations of blood production rates. The production rate for testosterone was 6.04±+1.66 vs. 3.69+±0.62 mg/d, whereas the production rate for 3adiol was 319±57 and 193+34 ,tg/d (P < 0.05 both groups). The irreversible conversion rate of testosterone to DHT was 3.1+0.4 and 3.5±0.9% (NS). The back conversion of 3adiol to DHT was high (68+25 vs. 81±+17, NS) indicating that 3adiol might cause BPH as a result of conversion to DHT in vivo. The conversion of DHT to 3adiol is reduced in the elderly group (15.8±2.6 and 6.3+1.4, P < 0.001). Since DHT formation in the prostate is a key event in development of BPH and blood DHT appears to be a measure of extrasplanchnic sexual target tissue activity, our in vivo studies suggest that the tissue increase in DHT may result from reduced metabolism and the activity of 3a-oxidoreduction favors the oxidative pathway in elderly men.
A B S T R A C T In vivo androgen kinetics were determined in six young (21-49 yr) and elderly men (62-77 yr) with prostate hyperplasia (BPH) . Steadystate infusions of [14C] testosterone and [3H]androstanediol (3adiol) were given, which allowed determination of the conversions testosterone -* dihydrotesterone (DHT) ti 3adiol. These infusions also yield metabolic clearance data which, together with measurement of nonisotopic steroid levels, yield estimations of blood production rates. The production rate for testosterone was 6.04±+1.66 vs. 3 .69+±0.62 mg/d, whereas the production rate for 3adiol was 319±57 and 193+34 ,tg/d (P < 0.05 both groups). The irreversible conversion rate of testosterone to DHT was 3.1+0.4 and 3.5±0.9% (NS). The back conversion of 3adiol to DHT was high (68+25 vs. 81±+17, NS) indicating that 3adiol might cause BPH as a result of conversion to DHT in vivo. The conversion of DHT to 3adiol is reduced in the elderly group (15.8±2.6 and 6.3+1.4, P < 0.001). Since DHT formation in the prostate is a key event in development of BPH and blood DHT appears to be a measure of extrasplanchnic sexual target tissue activity, our in vivo studies suggest that the tissue increase in DHT may result from reduced metabolism and the activity of 3a-oxidoreduction favors the oxidative pathway in elderly men. INTRODUCTION Dihydrotestosterone (DHT)l plays a central role in the formation of the prostate during fetal life and in the development ofboth human and canine prostate hyperplasia (BPH) in late adult life (1) (2) (3) . DHT levels are increased in BPH tissue, particularly in the peri-urethral area (4) . DHT is a potent growth factor (5) , and given in an appropriate dose induces BPH in young dogs (6, 7) . Another testosterone conversion product, androstanediol (3adiol), can induce canine BPH (8), however, it is not bound to target tissue receptors (9) and studies in vitro suggest that it is efficiently converted back to DHT (10) .
In man, secreted testosterone is peripherally converted into DHT and 3adiol by nongonadal tissues and a majority of both androgens in blood are derived from secreted testosterone (11, 12) . The importance of these observations was increased when it became clear that DHT conversion did not occur in muscle (13) , and we have demonstrated that both DHT and 3adiol are derived from conversion in extrasplanchnic tissue (14) . This work indicates that DHT and 3adiol production measured in the circulation may be a reflection of events occurring in sexual target tissue.
We report in vivo kinetic data that is suggestive of an alteration in androgen interconversion in the aging male. (12) .
METHODS
Assay of plasma androgens. The concenitrationi of sex steroids were measured by immunoassay methods described from our laboratory (15) (16) (17) . Samples were taken before the infusion every 20 min (three times) to minimize short-term episodic fluctuation in concentrations.
Kinetic study ofmetabolic clearance and conversion ratios.
[14C]testosterone and [3H]3adiol were given by constant infusion over a 2-h period as described (11, 12 for correction of losses and the plasma extracted with solvent as described (14) . The dried extracts were then chromatographed on a celite column (18) , collecting testosterone, DHT, and 3adiol fractions. The Bush A system (petroleum ether/ methanol/water, 5:4:1) was used for final purification of the testosterone and 3adiol and the Bush B3 system (Skellysolve C (Skelly Oil Co., Tulsa, Okla.) methanol/benzene/water 3.5:1.5:4: 1) for DHT. The conversion of testosterone to DHT was calculated from 54C counts and the other conversions were determined from 3H counts. An aliquot of samples after final purification was measured by radioimmunoassay for recovery correction. Testosterone purification losses were corrected for by [3H]-testosterone. Samples were counted for 150 or 200 min (3-4 x 50 min) and counting errors were <5% in all cases. For the critical determination of DHT to 3adiol conversions, counting rates were similar in both young and elderly groups due to reduction in metabolic clearance in the latter. In elderly patient R.R., ['4C]DHT was infused, yielding a much higher count rate, however, conversion values were not different from those obtained using [14C]testosterone. In the remaining studies of DHT conversion, counting rates ranged from 2 to 25 times background. We have previously shown that count rates handled in this manner, yield errors that are <5% (19) .
The testosterone and 3adiol metabolic clearance rates can be calculated from the ratio of counts infused per unit time and counts of the purified steroid per volume of plasma corrected for purification losses. The conversion ratios (testosterone-DHT, DHT-3adiol, and 3adiol-DHT) were determined as described (11, 12) as the ratio of counts in plasma as product and precursor steroid.
Proof of purity of labeled precursor and products in the circulation. Radiochemical purity was ascertained by constancy of the carbon-tritium ratio of compounds after acetylation and an additional chromatography step as described (11, 12 Table I and Fig. 2 . The irreversible conversion ratio of testosterone to DHT was 3.1±0.4 and 3.5±0.9% (NS). The back conversion of 3adiol to DHT is high in both groups (68±25 vs. 81±17%). No significant difference in formation of DHT from testosterone and 3adiol was FIGURE 1 Blood PR of testosterone (T), DHT, and 3adiol in young and elderly men with BPH. Production rates were calculated as the product of the metabolic clearance and morning blood levels. The DHT production was determined in another study (19) and is included for comparison. 0, young men (21-48 yr); 0, elderly (62-77 yr).
noted. However, the conversion rate of DHT to 3adiol is greatly reduced in the elderly group when compared with the young group (15.8+2.6 and 6.3±1.4%, P < 0.001).
DISCUSSION The MCR of all three androgens are reduced in elderly men. In previous studies we reported this for testosterone and DHT (20) . We now confirm this and document a reduction in MCR for 3adiol in elderly men. Reduced MCR of sex steroids in elderly men is probably the result of increased sex hormone-binding globulin levels (21) as well as reduced cardiac output and splanchnic blood flow in the older man. A significant reduction in the production rate ofboth testosterone and 3adiol is observed in the elderly male as a result (16) and the production rate of DHT, which is not reduced (20) .
Sexual tissue is capable of metabolizing testosterone to active hormonal products. Wilson and collaborators (4) studied this conversion in vitro and concluded that it was not increased fi BPH tissue when coenzyme (NADPH) was not added to the medium. Our kinetic studies describe the overall events ofblood production. Nevertheless, we suggest that these androgen interconversions may be an accurate reflection of what is occurring in prostate and other sexual tissue since muscle, the anabolic target for testosterone, lacks 5a-reductase and the splanchnic tissue is not the source of DHT. The conversion rate of testosterone to DHT measured in blood is not increased, in agreement with the tissue studies noted above. The in vivo PR of DHT is maintained, whereas that of 3adiol is reduced. In BPH tissue DHT levels are increased, whereas 3adiol levels are reduced (22) .
Our analysis ofthe conversion of3adiol back to DHT is also in agreement with in vitro studies of prostate tissue (10) . Most These in vivo kinetics suggest that the accumulation of DHT in sexual tissue is not the result of increased production, but reduced metabolism. This observation is in keeping with the in vitro observations that DHT levels are increased in prostate and seminal vesicles, that 3a-oxidoreductase activity in prostate is increased (23) , however, tissue levels of 3adiol are reduced (22) . We suggest from our blood kinetic studies that BPH is the result of a change in the state of this key enzyme whereby the oxidation pathway is favored over reduction, resulting in accumulation ofDHT, a potent growth stimulus to the prostate. Intervention would logically include either altering 5a-reductase activity or enhancing the reductive activity of 3a-oxidoreductase. ACKNOWLE DGMENTS This work was supported by National Institutes of Health grants AM 13710 and T32 AM 07119.
